Department of Physiology, Tulane University Health Sciences Center, School of Medicine, New Orleans, Louisiana 70112, USA.
Physiol Genomics. 2012 Apr 2;44(7):430-42. doi: 10.1152/physiolgenomics.00147.2011. Epub 2012 Feb 7.
The present study was aimed at determining the consequences of the disruption of guanylyl cyclase/natriuretic peptide receptor-A (GC-A/NPRA) gene (Npr1) on proinflammatory responses of nuclear factor kappa B, inhibitory kappa B kinase, and inhibitory kappa B alpha (NF-κB, IKK, IκBα) in the kidneys of mutant mice. The results showed that the disruption of Npr1 enhanced the renal NF-κB binding activity by 3.8-fold in 0-copy (-/-) mice compared with 2-copy (+/+) mice. In parallel, IKK activity and IκBα protein phosphorylation were increased by 8- and 11-fold, respectively, in the kidneys of 0-copy mice compared with wild-type mice. Interestingly, IκBα was reduced by 80% and the expression of proinflammatory cytokines and renal fibrosis were significantly enhanced in 0-copy mice than 2-copy mice. Treatment of 0-copy mice with NF-κB inhibitors andrographolide, pyrrolidine dithiocarbamate, and etanercept showed a substantial reduction in renal fibrosis, attenuation of proinflammatory cytokines gene expression, and significantly reduced IKK activity and IkBα phosphorylation. These findings indicate that the systemic disruption of Npr1 activates the renal NF-κB pathways in 0-copy mice, which transactivates the expression of various proinflammatory cytokines to initiate renal remodeling; however, inhibition of NF-κB pathway repairs the abnormal renal pathology in mutant mice.
本研究旨在确定破坏鸟苷酸环化酶/利钠肽受体-A(GC-A/NPRA)基因(Npr1)对核因子 kappa B(NF-κB)、抑制性 kappa B 激酶(IKK)和抑制性 kappa B 亚基(IκBα)的促炎反应的影响。结果表明,与 2 拷贝(+/+)小鼠相比,Npr1 缺失增强了 0 拷贝(-/-)小鼠肾脏 NF-κB 结合活性 3.8 倍。同时,与野生型小鼠相比,0 拷贝小鼠肾脏 IKK 活性和 IκBα 蛋白磷酸化分别增加了 8 倍和 11 倍。有趣的是,IκBα减少了 80%,0 拷贝小鼠的促炎细胞因子和肾脏纤维化表达明显增强。0 拷贝小鼠用 NF-κB 抑制剂穿心莲内酯、吡咯烷二硫代氨基甲酸盐和依那西普治疗,可显著减少肾脏纤维化、减弱促炎细胞因子基因表达,并显著降低 IKK 活性和 IκBα磷酸化。这些发现表明,Npr1 的全身缺失激活了 0 拷贝小鼠的肾脏 NF-κB 途径,该途径可反式激活各种促炎细胞因子的表达,从而引发肾脏重塑;然而,NF-κB 途径的抑制可修复突变小鼠的异常肾脏病理。